Published in J Neurol on August 18, 2010
Physical activity in subjects with multiple sclerosis with focus on gender differences: a survey. BMC Neurol (2014) 0.82
Sleep disturbances in patients with multiple sclerosis. Neurol Sci (2012) 0.81
The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigue. EPMA J (2016) 0.79
Use of Accelerometers to Measure Real-Life Physical Activity in Ambulatory Individuals with Multiple Sclerosis: A Pilot Study. Int J MS Care (2015) 0.79
Relationships among cognitive impairment, sleep, and fatigue in Parkinson's disease using the MDS-UPDRS. Parkinsonism Relat Disord (2014) 0.77
Central fatigue in multiple sclerosis: a review of the literature. J Spinal Cord Med (2016) 0.75
An inventory for measuring depression. Arch Gen Psychiatry (1961) 84.61
A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep (1991) 44.17
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology (1983) 40.64
The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol (1989) 13.32
Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the epworth sleepiness scale: failure of the MSLT as a gold standard. J Sleep Res (2000) 3.21
Sleepiness, fatigue, tiredness, and lack of energy in obstructive sleep apnea. Chest (2000) 2.15
Origin of fatigue in multiple sclerosis: review of the literature. Neurorehabil Neural Repair (2007) 1.86
Bright light therapy: improved sensitivity to its effects on rest-activity rhythms in Alzheimer patients by application of nonparametric methods. Chronobiol Int (1999) 1.77
Validation of the fatigue severity scale in a Swiss cohort. Sleep (2008) 1.72
Possible links between behavioral and physiological indices of tiredness, fatigue, and exhaustion in advanced cancer. Support Care Cancer (2007) 1.68
Distinguishing sleepiness and fatigue: focus on definition and measurement. Sleep Med Rev (2005) 1.46
Sleep and fatigue in multiple sclerosis. Mult Scler (2006) 1.30
Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS study. Sleep (2008) 1.22
A qualitative study to explore the concept of fatigue/tiredness in cancer patients and in healthy individuals. Support Care Cancer (1996) 1.20
The relationship of sleep disturbances and fatigue in multiple sclerosis. Arch Neurol (2004) 1.20
Validity of physical activity measures in ambulatory individuals with multiple sclerosis. Disabil Rehabil (2006) 1.17
Fatigue and sleep disturbance in multiple sclerosis. Eur J Neurol (2006) 1.17
Prevalence of 'poor sleep' among patients with multiple sclerosis: an independent predictor of mental and physical status. Sleep Med (2008) 1.13
Prevalence of sleep problems in individuals with multiple sclerosis. Mult Scler (2008) 1.13
Nocturnal sleep study in multiple sclerosis: correlations with clinical and brain magnetic resonance imaging findings. J Neurol Sci (1994) 1.12
Rasch analysis of the Fatigue Severity Scale in multiple sclerosis. Mult Scler (2008) 1.06
Symptom cluster as a predictor of physical activity in multiple sclerosis: preliminary evidence. J Pain Symptom Manage (2009) 1.05
Measuring fatigue in Parkinson's disease: a psychometric study of two brief generic fatigue questionnaires. J Pain Symptom Manage (2006) 1.04
Sleep disorders in patients with multiple sclerosis. Sleep Med Rev (2009) 1.00
Distinguishing between excessive daytime sleepiness and fatigue: toward improved detection and treatment. J Psychosom Res (2003) 1.00
Is there a differential impact of fatigue and physical disability on quality of life in multiple sclerosis? J Nerv Ment Dis (2002) 0.99
Measurement properties and hierarchical item structure of the Epworth Sleepiness Scale in Parkinson's disease. J Sleep Res (2007) 0.96
Restless leg syndrome, sleep quality and fatigue in multiple sclerosis patients. Braz J Med Biol Res (2008) 0.92
Daytime sleepiness and its evaluation. Sleep Med Rev (2002) 0.90
Rethinking the assessment of sleepiness. Sleep Med Rev (1998) 0.85
Measuring activity patterns using actigraphy in multiple sclerosis. Chronobiol Int (2007) 0.83
['Fatigue' in multiple sclerosis]. Nervenarzt (1999) 0.82
Sleep disturbance and fatigue in mild relapsing remitting multiple sclerosis patients on chronic immunomodulant therapy: an actigraphic study. Mult Scler (2009) 0.82
Sleep--wake and body core temperature rhythms in multiple sclerosis with fatigue. Clin Neurophysiol (2006) 0.76
Clinical complaints of daytime sleepiness and fatigue: how to distinguish and treat them, especially when they become 'excessive' or 'chronic'? Acta Neurol Belg (2010) 0.76
Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health A (2002) 3.54
Overproduction of the Bradyrhizobium japonicum c-type cytochrome subunits of the cbb3 oxidase in Escherichia coli. Biochem Biophys Res Commun (1998) 2.48
Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ Health Perspect (2001) 2.28
Biochemical and genetic characterization of benzylsuccinate synthase from Thauera aromatica: a new glycyl radical enzyme catalysing the first step in anaerobic toluene metabolism. Mol Microbiol (1998) 2.25
beta-oxidation of fatty acids in mitochondria, peroxisomes, and bacteria: a century of continued progress. Prog Lipid Res (1995) 2.14
[The development of a case group concept for patients with mental diseases]. Fortschr Neurol Psychiatr (2003) 2.08
CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity. J Immunol Methods (1994) 2.01
Bullying and victimization of primary school children in England and Germany: prevalence and school factors. Br J Psychol (2001) 2.00
[Benefit assessment in health services research and epidemiology]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2015) 1.97
Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: A 3-year follow-up study. Circulation (2000) 1.89
Disturbance of venous flow patterns in patients with transient global amnesia. Lancet (2000) 1.83
Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group. Gastroenterology (1997) 1.75
The metastasis-associated Mts1(S100A4) protein could act as an angiogenic factor. Oncogene (2001) 1.72
Complex visual hallucinations in the hemianopic field. J Neurol Neurosurg Psychiatry (1985) 1.70
Genome search for susceptibility loci of common idiopathic generalised epilepsies. Hum Mol Genet (2000) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Clinical significance of liver ischaemia after pancreatic resection. Br J Surg (2011) 1.59
Distribution pattern of inhaled ultrafine gold particles in the rat lung. Inhal Toxicol (2006) 1.58
Transcription of a novel mouse semaphorin gene, M-semaH, correlates with the metastatic ability of mouse tumor cell lines. Cancer Res (1998) 1.56
Fatty acid oxidation complex from Escherichia coli. Methods Enzymol (1981) 1.55
Evaluation of anterior knee joint instability with the Rolimeter. A test in comparison with manual assessment and measuring with the KT-1000 arthrometer. Knee Surg Sports Traumatol Arthrosc (1999) 1.51
Cognitive dysfunction in sleep disorders. Sleep Med Rev (2001) 1.47
Incidence of lower-limb amputations in the diabetic compared to the non-diabetic population. findings from nationwide insurance data, Germany, 2005-2007. Exp Clin Endocrinol Diabetes (2009) 1.45
Isolation of a multi-enzyme complex of fatty acid oxidation from Escherichia coli. Proc Natl Acad Sci U S A (1977) 1.45
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Diagnostic problems of desmoplastic melanoma in a boy with xeroderma pigmentosum. Dermatol Surg (1996) 1.39
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Successful long-term correction of autosomal recessive hyper-IgE syndrome due to DOCK8 deficiency by hematopoietic stem cell transplantation. Klin Padiatr (2010) 1.34
Acetylcholinesterase. Two types of modifications confer resistance to insecticide. J Biol Chem (1992) 1.31
Evidence for intermediate channeling in mitochondrial beta-oxidation. J Biol Chem (1995) 1.30
Human brain short chain L-3-hydroxyacyl coenzyme A dehydrogenase is a single-domain multifunctional enzyme. Characterization of a novel 17beta-hydroxysteroid dehydrogenase. J Biol Chem (1999) 1.27
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Changes of circadian blood pressure patterns after hemodynamic and thromboembolic brain infarction. Stroke (1994) 1.26
Long chain enoyl coenzyme A hydratase from pig heart. J Biol Chem (1974) 1.25
Prognostic relevance of pathological sympathetic activation after acute thromboembolic stroke. Neurology (2001) 1.24
Separation, properties, and regulation of acyl coenzyme A dehydrogenases from bovine heat and liver. Arch Biochem Biophys (1982) 1.24
Thiolases of Escherichia coli: purification and chain length specificities. J Bacteriol (1975) 1.23
Disease specific quality of life instruments in multiple sclerosis: validation of the Hamburg Quality of Life Questionnaire in Multiple Sclerosis (HAQUAMS). Mult Scler (2001) 1.22
Purification and properties of a pig heart thiolase with broad chain length specificity and comparison of thiolases from pig heart and Escherichia coli. J Biol Chem (1978) 1.21
Five different enzymatic activities are associated with the multienzyme complex of fatty acid oxidation from Escherichia coli. J Bacteriol (1979) 1.21
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
[Suture technique for perforating keratoplasty (author's transl)]. Klin Monbl Augenheilkd (1976) 1.18
The PBX-regulating protein PREP1 is present in different PBX-complexed forms in mouse. Mech Dev (1999) 1.15
Sleep apnea syndrome and cerebral hemodynamics. Chest (1996) 1.15
Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44(+)) and T (HLA-DR(+)) cells. Bone Marrow Transplant (2009) 1.14
The influence of thyroxine and adrenal cortical extract on the oxygen consumption of adrenalectomized rats. J Physiol (1948) 1.14
Purification and properties of pig heart crotonase and the presence of short chain and long chain enoyl coenzyme A hydratases in pig and guinea pig tissues. J Biol Chem (1977) 1.14
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
Total deposition of therapeutic particles during spontaneous and controlled inhalations. J Pharm Sci (2000) 1.13
A human brain L-3-hydroxyacyl-coenzyme A dehydrogenase is identical to an amyloid beta-peptide-binding protein involved in Alzheimer's disease. J Biol Chem (1998) 1.13
Nucleotide sequence of the fadA gene. Primary structure of 3-ketoacyl-coenzyme A thiolase from Escherichia coli and the structural organization of the fadAB operon. J Biol Chem (1990) 1.13
Delayed neuronal death after brain trauma involves p53-dependent inhibition of NF-kappaB transcriptional activity. Cell Death Differ (2007) 1.11
The structure of the multienzyme complex of fatty acid oxidation from Escherichia coli. J Biol Chem (1981) 1.11
The effect of laser microsurgery on cytoplasmic strands and cytoplasmic streaming in isolated plant protoplasts. Eur J Cell Biol (1984) 1.11
Topographical analysis of sleep spindle activity. Neuropsychobiology (1992) 1.11
Ultrastructural changes in the trabecular meshwork of human eyes treated with corticosteroids. Arch Ophthalmol (1997) 1.11
Orthotopic corneal transplantation in the mouse--a new surgical technique with minimal endothelial cell loss. Graefes Arch Clin Exp Ophthalmol (1996) 1.09
Daytime variation in performance and tiredness/sleepiness ratings in patients with insomnia, narcolepsy, sleep apnea and normal controls. J Sleep Res (2004) 1.09
[Studies on the purification and characterization of dipeptidyl aminopeptidase IV]. Acta Biol Med Ger (1974) 1.08
Characterization of PECI, a novel monofunctional Delta(3), Delta(2)-enoyl-CoA isomerase of mammalian peroxisomes. J Biol Chem (1999) 1.08
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
Preliminary experiences with triple therapy including nelfinavir and two reverse transcriptase inhibitors in previously untreated HIV-infected children. AIDS (1999) 1.06
3-Hydroxyacyl-CoA epimerases of rat liver peroxisomes and Escherichia coli function as auxiliary enzymes in the beta-oxidation of polyunsaturated fatty acids. J Biol Chem (1986) 1.06
Changes of circadian blood pressure patterns and cardiovascular parameters indicate lateralization of sympathetic activation following hemispheric brain infarction. J Neurol (1995) 1.06
Noninvasive prediction of intracranial pressure curves using transcranial Doppler ultrasonography and blood pressure curves. Stroke (1997) 1.06
Dimethyl sulfoxide can initiate cell divisions of arrested callus protoplasts by promoting cortical microtubule assembly. Proc Natl Acad Sci U S A (1984) 1.06
[Multimorbidity and successful aging: the population-based KORA-Age study]. Z Gerontol Geriatr (2011) 1.05
Quality of life in 1000 patients with early relapsing-remitting multiple sclerosis. Eur J Neurol (2009) 1.05
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
Short-chain and long-chain enoyl-CoA hydratases from pig heart muscle. Methods Enzymol (1981) 1.04
Further evidence for Borrelia burgdorferi infection in morphea and lichen sclerosus et atrophicus confirmed by DNA amplification. J Invest Dermatol (1993) 1.04
Rat heart fatty acid-binding protein is highly homologous to the murine adipocyte 422 protein and the P2 protein of peripheral nerve myelin. J Biol Chem (1986) 1.04
Delivering the diagnosis of MS--results of a survey among patients and neurologists. Acta Neurol Scand (2003) 1.03
Fatty acid oxidation in rat brain is limited by the low activity of 3-ketoacyl-coenzyme A thiolase. J Biol Chem (1987) 1.03
CCME, a nuclear-encoded heme-binding protein involved in cytochrome c maturation in plant mitochondria. J Biol Chem (2000) 1.03
Noninvasive cardiac output measurement by arterial pulse analysis compared with inert gas rebreathing. J Appl Physiol (1985) (1993) 1.02
Rabbit corneal allograft survival following topical administration of cyclosporin A. Invest Ophthalmol Vis Sci (1982) 1.02
Muir-Torre syndrome - treatment with isotretinoin and interferon alpha-2a can prevent tumour development. Dermatology (2000) 1.01
High-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive non-Hodgkin lymphoma (NHL) in adults. Cochrane Database Syst Rev (2008) 1.01
Immunohistology of corneal wound healing after photorefractive keratectomy and laser in situ keratomileusis. wachtlin@ukbf.fu-berlin.de. J Refract Surg (1999) 1.01
Prognostic B-cell epitopes on the flagellar protein of Borrelia burgdorferi. Infect Immun (1992) 1.01
Long-chain acyl-CoA dehydrogenase is a key enzyme in the mitochondrial beta-oxidation of unsaturated fatty acids. Biochim Biophys Acta (2000) 1.01
Facial affect recognition in the course of schizophrenia. Eur Arch Psychiatry Clin Neurosci (1996) 1.01
Antiviral efficacy, tolerability and pharmacokinetics of efavirenz in an unselected cohort of HIV-infected children. J Antimicrob Chemother (2008) 1.01
The German Mouse Clinic: a platform for systemic phenotype analysis of mouse models. Curr Pharm Biotechnol (2009) 1.01
Molecular characterization of Saccharomyces cerevisiae Delta3, Delta2-enoyl-CoA isomerase. J Biol Chem (1998) 1.00
Inhalation of 5-aminolevulinic acid: a new technique for fluorescence detection of early stage lung cancer. J Photochem Photobiol B (1996) 1.00
A Sendai virus vector leading to the efficient expression of mutant M proteins interfering with virus particle budding. Virology (1996) 1.00
Development of the osteoblast phenotype in primary human osteoblasts in culture: comparison with rat calvarial cells in osteoblast differentiation. J Cell Biochem (1999) 1.00
Determination of lycopene and beta-carotene content in tomato fruits and related products: Comparison of FT-Raman, ATR-IR, and NIR spectroscopy. Anal Chem (2006) 1.00
Short-chain 3-hydroxy-2-methylacyl-CoA dehydrogenase from rat liver: purification and characterization of a novel enzyme of isoleucine metabolism. Arch Biochem Biophys (1995) 0.99
Search for supersymmetry in events with three leptons and missing transverse momentum in √[s]=7 TeV pp collisions with the ATLAS detector. Phys Rev Lett (2012) 0.99
Dosimetry and toxicology of inhaled ultrafine particles. Biomarkers (2009) 0.98
Studies on the mechanism of fatty acid synthesis. XXII. Salt activation of the fatty acid-synthesizing enzymes of Escherichia coli. J Biol Chem (1969) 0.98
On the rate-determining step of fatty acid oxidation in heart. Inhibition of fatty acid oxidation by 4-pentenoic acid. J Biol Chem (1978) 0.98
Increased fine particle deposition in women with asymptomatic nonspecific airway hyperresponsiveness. Am J Respir Crit Care Med (1999) 0.98
Nucleotide sequence of the promoter and fadB gene of the fadBA operon and primary structure of the multifunctional fatty acid oxidation protein from Escherichia coli. Biochemistry (1991) 0.98
PKNOX1, a gene encoding PREP1, a new regulator of Pbx activity, maps on human chromosome 21q22.3 and murine chromosome 17B/C. Genomics (1998) 0.98